Bracebridge Capital LLC’s Alvotech ALVO Stock Holding History

Bracebridge Capital LLC’s Portfolio ALVO Stock Details ALVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.9M	Buy	4,038,637 +1,333,333	+49%	+$4.77M	0.27%	17
2026 Q1	$9.28M	Hold	2,705,304	–	–	0.25%	18
2025 Q4	$13.9M	Hold	2,705,304	–	–	0.45%	13
2025 Q3	$22.2M	Hold	2,705,304	–	–	1.16%	9
2025 Q2	$24.7M	Hold	2,705,304	–	–	1.32%	13
2025 Q1	$26.2M	Hold	2,705,304	–	–	1.77%	6
2024 Q4	$35.8M	Hold	2,705,304	–	–	2.53%	8
2024 Q3	$32.2M	Hold	2,705,304	–	–	5.25%	3
2024 Q2	$32.9M	Hold	2,705,304	–	–	5.96%	5
2024 Q1	$33.1M	Sell	2,705,304 -1,655,220	-38%	-$24.2M	4.08%	6
2023 Q4	$50.1M	Hold	4,360,524	–	–	10.79%	4
2023 Q3	$39.8M	Hold	4,360,524	–	–	6.32%	3
2023 Q2	$33.8M	Sell	4,360,524 -54,737	-1%	-$509K	18.54%	1
2023 Q1	$57M	Sell	4,415,261 -2,179,804	-33%	-$27.9M	15.2%	2
2022 Q4	$66M	Sell	6,595,065 -386,322	-6%	-$2.7M	6.16%	3
2022 Q3	$47.2M	Hold	6,981,387	–	–	8.31%	4
2022 Q2	$57.3M	Buy	+6,981,387	New	+$65M	9.08%	3

Other funds holding ALVO

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Littlejohn & Co Greenwich, Connecticut $78.6M AUM 1.93% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Bracebridge Capital LLC's ALVO Position: Q2 2026 in Review

Bracebridge Capital LLC increased its Alvotech (ALVO) stake by 49% in Q2 2026, buying an estimated $4.77M and bringing the position to 4,038,637 shares worth $14.9M. The position accounts for 0.27% of the portfolio, ranked #17.

Bracebridge Capital LLC first reported a position in ALVO in Q2 2022 and has held it in 17 quarters since. The position peaked at $66M in Q4 2022. 72 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

Bracebridge Capital LLC held 4,038,637 shares of Alvotech worth $14.9M as of Q2 2026.
Bracebridge Capital LLC bought 1,333,333 Alvotech shares in Q2 2026, an estimated $4.77M.
Alvotech made up 0.27% of Bracebridge Capital LLC's portfolio in Q2 2026, its #17 holding.
Bracebridge Capital LLC first reported a position in Alvotech in Q2 2022 and has held it in 17 quarters since.
Bracebridge Capital LLC's Alvotech position peaked at $66M in Q4 2022.
72 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on Bracebridge Capital LLC's 13F filing for Q2 2026, filed 14 Aug 2026.